Interpace Biosciences (IDXG) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Agriculture Air Clean Environment Environmental Environmental Protection Extraction Hazard Materials Nature Offset Oil Pandemic Raw Materials Waste Access Benefits Black Citizenship Collective Bargaining Community Culture Customer Customer Satisfaction Cybersecurity Data Privacy Data Security Death Disability Diversity Employee Engagement Health and Safety Health Care Healthcare Hire Hiring Injuries Injury Opioid Overtime Perquisites Privacy Recall Recruit Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Society Supplier Supply Chain Talent Union Workers Workforce Workplace Safety Anti-corruption Assessment Assurance Attorney General Attorneys General Audit Bonus Bribe Bribery Chronic Classified Clawback Commitment Corporate Governance Corporate Purpose Department of Enterprise Risk Management Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Innovate Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Materiality Mission Oversee Oversight Perquisite Plaintiff Political Expenditures Procurement Purpose Quality Standard R&D Recoup Reputation Research and Development Responsibility Responsible Special Meeting Strategy Sustainable Targets Tax Tenure Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On November 10, 2022, the Company held its 2022 annual meeting of stockholders (the “2022 Annual Meeting”). The following proposals were voted on and were approved by the Company’s stockholders at the 2022 Annual Meeting with the stockholders having voted as set forth below:

I. Election of one Class I director to serve until the 2025 annual meeting or until such director’s successor is duly elected and qualified.

Name		For		Withhold		Broker Non-Votes
Stephen J. Sullivan		8,793,313		820,085		1,522,847

II. Approval of the Plan Amendment.

For		Against		Abstain		Broker Non-Votes
9,498,523		88,097		26,778		1,522,847

III. Approval of the ESPP Amendment.

For		Against		Abstain		Broker Non-Votes
9,501,243		85,297		26,858		1,522,847

IV. To grant the board of directors of the Company (the “Board”) discretionary authority to amend the Company’s Certificate of Incorporation, as amended, to effect a reverse stock split of its common stock within the range of 1-for-2 to 1-for-10 with the exact ratio, if any, to be determined by the Board, but not later than one year after stockholder approval thereof.

For		Against		Abstain		Broker Non-Votes
10,270,993		800,853		64,399		0

V. Ratification of the appointment of EisnerAmper, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

For		Against		Abstain		Broker Non-Votes
11,041,434		35,207		59,604		0